Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Pharmacy Department, University Hospital, Newark, NJ, USA.
Hosp Pract (1995). 2023 Aug;51(3):168-173. doi: 10.1080/21548331.2023.2225964. Epub 2023 Jun 26.
The primary objective was to determine the financial resources allocated to docusate at a representative U.S. tertiary care center. Secondary objectives included comparing docusate utilization between two tertiary care centers, and exploring alternative uses for the funds spent on docusate.
The study population included all patients 18 years and older admitted to University Hospital in Newark, New Jersey. Every scheduled docusate prescription for the study population between January 1, 2015 and December 31, 2019 was collected. The annual total cost associated with docusate use per year was calculated. The 2015 data from this study and a 2015 McGill University Health Centre study were compared. Also, alternative uses for the money utilized on docusate were assessed.
Over the study period, 37,034 docusate prescriptions and 265,123 docusate doses were recorded. The average cost of prescribing docusate was $25,624.14 per year and $49.37 per hospital bed per year. A comparison between the 2015 data of University Hospital and McGill showed that McGill prescribed 107 doses and spent $10.09 more per hospital bed than University Hospital. Finally, alternative uses for the average yearly spending on docusate equated to 0.35 the salary of a nurse, 0.51 the salary of a secretary, 20.66 colonoscopies, 27.00 upper endoscopies, 186.71 mammograms, 1,399.37 doses of polyethylene glycol 3350, 3,826.57 doses of lactulose, or 4,583.80 doses of psyllium.
A single average size tertiary care hospital spent about $25,000 yearly on docusate despite its lack of clinical effectiveness. While this amount is small compared to an overall hospital budget, when considering likely comparable docusate use at the U.S's 6,090 hospitals, the economic burden of docusate becomes significant. The funds currently being used on docusate could be redirected to alternative, more cost-effective purposes.
主要目的是确定美国一家三级保健中心用于多库酯的财务资源。次要目标包括比较两家三级保健中心的多库酯使用情况，并探讨用于多库酯的资金的其他用途。
研究人群包括新泽西州纽瓦克大学医院所有 18 岁及以上的住院患者。收集了 2015 年 1 月 1 日至 2019 年 12 月 31 日期间研究人群中每例计划多库酯处方的信息。计算了每年与多库酯使用相关的总费用。将本研究 2015 年的数据与 2015 年麦吉尔大学健康中心的研究数据进行了比较。还评估了用于多库酯的资金的其他用途。
在研究期间，共记录了 37034 例多库酯处方和 265123 剂多库酯。每年开具多库酯的平均费用为 25624.14 美元，每间医院病床每年 49.37 美元。将大学医院和麦吉尔大学 2015 年的数据进行比较，结果显示麦吉尔大学的处方剂量为 107 剂，每间医院病床的费用比大学医院多 10.09 美元。最后，平均每年用于多库酯的支出的其他用途相当于 0.35 名护士的工资、0.51 名秘书的工资、20.66 次结肠镜检查、27.00 次上消化道内镜检查、186.71 次乳房 X 光检查、1399.37 剂聚乙二醇 3350、3826.57 剂乳果糖或 4583.80 剂车前子。
尽管多库酯缺乏临床疗效，但一家普通规模的三级保健医院每年在多库酯上的花费约为 25000 美元。虽然与医院总预算相比，这一数额很小，但考虑到美国 6090 家医院可能类似的多库酯使用情况，多库酯的经济负担变得非常显著。目前用于多库酯的资金可以重新用于其他更具成本效益的用途。
